Table 2.
Treatment options for Behçet’s and Crohn’s disease
|
BD |
CD |
|||
| Extraintestinal BD | Intestinal BD | Extraintestinal CD | Intestinal CD | |
| Colchicine | S, M, A | - | - | - |
| Corticosteroids | All manifestations | + | All manifestations | + |
| Azathioprine | S, M, O, V, N | + | S | + |
| 6-mercaptopurine | - | ?? | - | + |
| Cyclosporine A | O | - | - | - |
| Interferon-alpha | O, N | - | - | - |
| Mycophenolate Mofetil | O | - | - | - |
| Cyclophosphamide | O, V, N | - | - | - |
| Methotrexate | A, N | - | A, S | - |
| Sulfasalazine | A | + | A | + |
| Mesalazine | - | + | - | + |
| Anti-TNF agents | A, O, N | + | A, S, O | + |
A: Arthritis; S: Skin; M: Mucosal; O: Ocular; V: Vascular; N: Neurogical Involvement; (+): Effective; (-): Non-Effective; BD: Behçet’s Disease; CD: Crohn’s disease.